Innate Immune Receptors as Dynamic Modulators of Extrafollicular Autoimmune B Cell Response
Immunological Reviews · 2025-03 · 330 (1)
DOI: 10.1111/imr.70005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 07.02.2025. Verfasst von Danni Yi-Dan Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Immunity, Innate, Autoimmunity, B-Lymphocytes, Autoimmune Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Lupus Research Alliance, CIHR, NIAMS NIH HHS.
Abstract (Originalsprache)
The immune system relies on carefully calibrated cellular machineries to enable distinction between endogenous and foreign molecules, with autoimmunity arising when this balance is disrupted. As potent autoantibody factories, B cells are major drivers of many autoimmune diseases. A significant fraction of patients affected by chronic autoimmune diseases such as systemic lupus erythematosus (SLE) exhibit pathogenic accumulation of B‐cell subsets that are believed to be derived from the extrafollicular (EF) differentiation pathway. These B‐cell subsets, although variously named and exhibiting intrinsic heterogeneity, are all poised producers of autoantibodies that correlate with patient pathophysiology. In addition, they are often characterized by biomarkers known to drive the innate immune response, including toll‐like receptors and complement receptors. Although many innate receptors have well‐established functions in myeloid cells and other immune cell types, their B cell‐specific functions are still under active investigation and are crucial for understanding the molecular pathways that drive B‐cell breaks of tolerance. In this review, we summarize studies on innate immune receptors that serve prominent roles in regulating EF B‐cell activation in health and autoimmunity. By discussing independent and collaborative functions of these receptors, we hope to provide new perspectives in autoimmune disease signature research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Harvard Graduate Program in Virology, Boston, Massachusetts, USA.
- Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Michael C Carroll
Förderung
- Lupus Research Alliance
- CIHR
- NIAMS NIH HHS
- NIMH NIH HHS
- U.S. Department of Defense
- NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Zhu, D. Y., Castrillon, C., & Carroll, M. C. (2025). Innate Immune Receptors as Dynamic Modulators of Extrafollicular Autoimmune B Cell Response. Immunological Reviews, 330(1). https://doi.org/10.1111/imr.70005
Vancouver
Zhu DY, Castrillon C, Carroll MC. Innate Immune Receptors as Dynamic Modulators of Extrafollicular Autoimmune B Cell Response. Immunological Reviews. 2025;330(1). doi:10.1111/imr.70005
BibTeX
@article{Zhu2025,
author = {Zhu, Danni Yi-Dan and Castrillon, Carlos and Carroll, Michael C},
title = {Innate Immune Receptors as Dynamic Modulators of Extrafollicular Autoimmune B Cell Response},
journal = {Immunological Reviews},
year = {2025},
volume = {330},
number = {1},
doi = {10.1111/imr.70005}
}
EUVIMED